Sysmex Corporation 6869.T Stock
Sysmex Corporation Price Chart
Sysmex Corporation 6869.T Financial and Trading Overview
Sysmex Corporation stock price | 2666 JPY |
Previous Close | 9881 JPY |
Open | 9850 JPY |
Bid | 9788 JPY x 0 |
Ask | 9817 JPY x 0 |
Day's Range | 9784 - 9902 JPY |
52 Week Range | 7380 - 10245 JPY |
Volume | 720.1K JPY |
Avg. Volume | 450.31K JPY |
Market Cap | 2.05T JPY |
Beta (5Y Monthly) | 0.619157 |
PE Ratio (TTM) | 43.888042 |
EPS (TTM) | 71.94 JPY |
Forward Dividend & Yield | 84 (0.83%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 9715.4 JPY |
6869.T Valuation Measures
Enterprise Value | 2.04T JPY |
Trailing P/E | 43.888042 |
Forward P/E | 33.983036 |
PEG Ratio (5 yr expected) | 2.93 |
Price/Sales (ttm) | 5.0033855 |
Price/Book (mrq) | 5.2982965 |
Enterprise Value/Revenue | 4.975 |
Enterprise Value/EBITDA | 18.935 |
Trading Information
Sysmex Corporation Stock Price History
Beta (5Y Monthly) | 0.619157 |
52-Week Change | 28.91% |
S&P500 52-Week Change | 20.43% |
52 Week High | 10245 JPY |
52 Week Low | 7380 JPY |
50-Day Moving Average | 9215.66 JPY |
200-Day Moving Average | 8536.75 JPY |
6869.T Share Statistics
Avg. Volume (3 month) | 450.31K JPY |
Avg. Daily Volume (10-Days) | 583.57K JPY |
Shares Outstanding | 209.24M |
Float | 149.97M |
Short Ratio | N/A |
% Held by Insiders | 26.79% |
% Held by Institutions | 30.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 80 |
Trailing Annual Dividend Yield | 0.80% |
5 Year Average Dividend Yield | 83.00% |
Payout Ratio | 0.3539 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 11.15% |
Operating Margin (ttm) | 18.52% |
Gross Margin | 52.63% |
EBITDA Margin | 26.27% |
Management Effectiveness
Return on Assets (ttm) | 9.36% |
Return on Equity (ttm) | 12.40% |
Income Statement
Revenue (ttm) | 410.5B JPY |
Revenue Per Share (ttm) | 1961.99 JPY |
Quarterly Revenue Growth (yoy) | 6.60% |
Gross Profit (ttm) | N/A |
EBITDA | 107.86B JPY |
Net Income Avi to Common (ttm) | 45.78B JPY |
Diluted EPS (ttm) | 223.66 |
Quarterly Earnings Growth (yoy) | -5.29% |
Balance Sheet
Total Cash (mrq) | 70.33B JPY |
Total Cash Per Share (mrq) | 336.14 JPY |
Total Debt (mrq) | 22.59B JPY |
Total Debt/Equity (mrq) | 5.82 JPY |
Current Ratio (mrq) | 2.66 |
Book Value Per Share (mrq) | 1852.671 |
Cash Flow Statement
Operating Cash Flow (ttm) | 68.84B JPY |
Levered Free Cash Flow (ttm) | 18.85B JPY |
Profile of Sysmex Corporation
Country | Japan |
State | N/A |
City | Kobe |
Address | 1-5-1 Wakinohama-kaigandori |
ZIP | 651-0073 |
Phone | 81 78 265 0500 |
Website | https://www.sysmex.co.jp |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Q&A For Sysmex Corporation Stock
What is a current 6869.T stock price?
Sysmex Corporation 6869.T stock price today per share is 2666 JPY.
How to purchase Sysmex Corporation stock?
You can buy 6869.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sysmex Corporation?
The stock symbol or ticker of Sysmex Corporation is 6869.T.
Which industry does the Sysmex Corporation company belong to?
The Sysmex Corporation industry is Medical Instruments & Supplies.
How many shares does Sysmex Corporation have in circulation?
The max supply of Sysmex Corporation shares is 207.8M.
What is Sysmex Corporation Price to Earnings Ratio (PE Ratio)?
Sysmex Corporation PE Ratio is 37.05866000 now.
What was Sysmex Corporation earnings per share over the trailing 12 months (TTM)?
Sysmex Corporation EPS is 71.94 JPY over the trailing 12 months.
Which sector does the Sysmex Corporation company belong to?
The Sysmex Corporation sector is Healthcare.